BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12172340)

  • 1. Effect of citalopram treatment on relationship between platelet serotonin functions and the Karolinska scales of personality in panic patients.
    Neuger J; Wistedt B; Aberg-Wistedt A; Stain-Malmgren R
    J Clin Psychopharmacol; 2002 Aug; 22(4):400-5. PubMed ID: 12172340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of citalopram treatment on platelet serotonin function in panic disorders.
    Neuger J; Wistedt B; Sinner B; Aberg-Wistedt A; Stain-Malmgren R
    Int Clin Psychopharmacol; 2000 Mar; 15(2):83-91. PubMed ID: 10759339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.
    Esler M; Lambert E; Alvarenga M; Socratous F; Richards J; Barton D; Pier C; Brenchley C; Dawood T; Hastings J; Guo L; Haikerwal D; Kaye D; Jennings G; Kalff V; Kelly M; Wiesner G; Lambert G
    Stress; 2007 Aug; 10(3):295-304. PubMed ID: 17613943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet serotonin transporter function after short-term paroxetine treatment in patients with panic disorder.
    Kang EH; Shim HB; Kim KJ; Park JE; Lee IS; Yu BH
    Psychiatry Res; 2010 Apr; 176(2-3):250-3. PubMed ID: 20207008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders.
    Humble M; Wistedt B
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():21-39. PubMed ID: 1431019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in personality traits during treatment with sertraline or citalopram.
    Ekselius L; Von Knorring L
    Br J Psychiatry; 1999 May; 174():444-8. PubMed ID: 10616614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B; Baldwin DS; Dolberg OT; Andersen HF; Stein DJ
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.
    Seedat S; van Rheede van Oudtshoorn E; Muller JE; Mohr N; Stein DJ
    Int Clin Psychopharmacol; 2003 Sep; 18(5):279-84. PubMed ID: 12920388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pharmacotherapy on personality disorders in panic disorder: a one year naturalistic study.
    Marchesi C; Cantoni A; Fontò S; Giannelli MR; Maggini C
    J Affect Disord; 2005 Dec; 89(1-3):189-94. PubMed ID: 16209891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants.
    Li X; Fan Y; Xiao S; Peng S; Dong X; Zheng X; Liu CC; Li H; Xiao Z
    J Affect Disord; 2015 Nov; 187():84-90. PubMed ID: 26321259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM; Gergel I; Li D
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels.
    Herrán A; Ramírez ML; Carrera M; García-Unzueta MT; Sierra-Biddle D; Rodríguez-Cabo B; Ayestarán A; Hoyuela F; Vázquez-Barquero JL
    J Clin Psychopharmacol; 2006 Oct; 26(5):538-40. PubMed ID: 16974205
    [No Abstract]   [Full Text] [Related]  

  • 14. Citalopram and panic disorder.
    Bertani A; Perna G; Politi E; Bellodi L
    Depress Anxiety; 1996-1997; 4(5):253. PubMed ID: 9167795
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of pharmacological treatment on temperament and character in panic disorder.
    Marchesi C; De Panfilis C; Cantoni A; Giannelli MR; Maggini C
    Psychiatry Res; 2008 Mar; 158(2):147-54. PubMed ID: 18234355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of salbutamol-induced panic disorder with citalopram.
    Rihmer Z
    Eur Neuropsychopharmacol; 1997 Aug; 7(3):241-2. PubMed ID: 9213085
    [No Abstract]   [Full Text] [Related]  

  • 17. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram in the treatment of depression and other potential uses in psychiatry.
    Tan JY; Levin GM
    Pharmacotherapy; 1999 Jun; 19(6):675-89. PubMed ID: 10391413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety.
    Hogg S; Michan L; Jessa M
    Neuropharmacology; 2006 Jul; 51(1):141-5. PubMed ID: 16678216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citalopram-induced major depression in a patient with panic disorder - a case report.
    Hofmann P; Conrad R
    Psychiatr Danub; 2012 Mar; 24(1):94-6. PubMed ID: 22447093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.